We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Anthem (ANTM) & Units Receive Medicare Star Ratings From CMS
Read MoreHide Full Article
Anthem, Inc. and its units have recently received Star Ratings from the Centers for Medicare and Medicaid Services (“CMS”) for its Medicare Advantage (MA) health plans.
Per CMS, in 2018, more than 60% of Anthem’s Medicare Advantage members will be enrolled in MA plans that have achieved four stars or more, with five stars being the highest limit.
The Know-How of Star Ratings
Star Ratings are calculated every year on a scale of one to five stars (five being the highest limit), and are subject to change. CMS rates MA and Medicare prescription drug plans (PDP) on the basis of how well they provide medication coverage along with a number of factors like the quality of customer service being provided, count and frequency of member complaints, members’ experience with drug plans and the level of safety associated with the drugs.
While assigning the ratings, CMS considers two parameters of the MA and PDPs namely, quality and performance. The MA plans are rated on the basis of their ability to take care of the members’ overall health, help them manage chronic conditions, ensure positive experiences with health plan, attain member satisfaction and offer effective customer service.
Rationale Behind the Ratings
These Star Ratings reflect Anthem’s multi-year focus on the improvement of the quality of its Medicare offerings. It further intends to improve the performance of its health plans moving into 2019. Only 22% members were enrolled in four-star or better plans in 2016 Star Ratings.
Over the last four years, Anthem remained committed to upgrade the performance and quality of its Medicare platform. It has been diligently engaged in providing the MA members greater access to high-quality health care at an affordable cost. The company looks forward to continuously customize its Medicare Advantage product portfolio with further innovation.
Anthem and its affiliated health plans have made significant investments for expanding MA plans product portfolio and services areas. They also worked on local health plan staffing along with strengthening the level of engagement between provider and member. On the back of these efforts, Anthem expects its Medicare business to grow further in 2018.
Share Price Performance
Anthem’s continues focus on creating customer delight has helped the stock retain shareholders’ confidence. In the last year, its shares have gained 57%, outperforming the industry’s rally of 44%.
Investors interested in this space can consider stocks like Humana Inc (HUM - Free Report) , Aetna, Inc , and Centene Corp (CNC - Free Report) . While Humana sports a Zacks Rank #1, the other two stocks carry a Zacks Rank #2 (Buy).
Humana’s earnings surpassed expectations in three of the last four quarters with an average beat of nearly 8.6%.
Aetna’s earnings surpassed expectations in each of the last four quarters with an average beat of nearly 19%.
Centene delivered positive surprises in three of the last four quarters with an average beat of 7.7%.
4 Stocks to Watch after the Massive Equifax Hack
Cybersecurity stocks spiked on recent news of a data breach affecting 143 million Americans. But which stocks are the best buy candidates right now? And what does the future hold for the cybersecurity industry?
Equifax is just the most recent victim. Computer hacking and identity theft are more common than ever. Zacks has just released Cybersecurity! An Investor’s Guide to inform Zacks.com readers about this $170 billion/year space. More importantly, it highlights 4 cybersecurity picks with strong profit potential.
Image: Bigstock
Anthem (ANTM) & Units Receive Medicare Star Ratings From CMS
Anthem, Inc. and its units have recently received Star Ratings from the Centers for Medicare and Medicaid Services (“CMS”) for its Medicare Advantage (MA) health plans.
Per CMS, in 2018, more than 60% of Anthem’s Medicare Advantage members will be enrolled in MA plans that have achieved four stars or more, with five stars being the highest limit.
The Know-How of Star Ratings
Star Ratings are calculated every year on a scale of one to five stars (five being the highest limit), and are subject to change. CMS rates MA and Medicare prescription drug plans (PDP) on the basis of how well they provide medication coverage along with a number of factors like the quality of customer service being provided, count and frequency of member complaints, members’ experience with drug plans and the level of safety associated with the drugs.
While assigning the ratings, CMS considers two parameters of the MA and PDPs namely, quality and performance. The MA plans are rated on the basis of their ability to take care of the members’ overall health, help them manage chronic conditions, ensure positive experiences with health plan, attain member satisfaction and offer effective customer service.
Rationale Behind the Ratings
These Star Ratings reflect Anthem’s multi-year focus on the improvement of the quality of its Medicare offerings. It further intends to improve the performance of its health plans moving into 2019. Only 22% members were enrolled in four-star or better plans in 2016 Star Ratings.
Over the last four years, Anthem remained committed to upgrade the performance and quality of its Medicare platform. It has been diligently engaged in providing the MA members greater access to high-quality health care at an affordable cost. The company looks forward to continuously customize its Medicare Advantage product portfolio with further innovation.
Anthem and its affiliated health plans have made significant investments for expanding MA plans product portfolio and services areas. They also worked on local health plan staffing along with strengthening the level of engagement between provider and member. On the back of these efforts, Anthem expects its Medicare business to grow further in 2018.
Share Price Performance
Anthem’s continues focus on creating customer delight has helped the stock retain shareholders’ confidence. In the last year, its shares have gained 57%, outperforming the industry’s rally of 44%.
Zacks Rank & Stocks to Consider
Anthem presently carries a Zacks Rank #3 (Hold).You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Investors interested in this space can consider stocks like Humana Inc (HUM - Free Report) , Aetna, Inc , and Centene Corp (CNC - Free Report) . While Humana sports a Zacks Rank #1, the other two stocks carry a Zacks Rank #2 (Buy).
Humana’s earnings surpassed expectations in three of the last four quarters with an average beat of nearly 8.6%.
Aetna’s earnings surpassed expectations in each of the last four quarters with an average beat of nearly 19%.
Centene delivered positive surprises in three of the last four quarters with an average beat of 7.7%.
4 Stocks to Watch after the Massive Equifax Hack
Cybersecurity stocks spiked on recent news of a data breach affecting 143 million Americans. But which stocks are the best buy candidates right now? And what does the future hold for the cybersecurity industry?
Equifax is just the most recent victim. Computer hacking and identity theft are more common than ever. Zacks has just released Cybersecurity! An Investor’s Guide to inform Zacks.com readers about this $170 billion/year space. More importantly, it highlights 4 cybersecurity picks with strong profit potential.
Get the new Investing Guide now>>